BUZZ-UK's Evoke jumps after agreeing to $326 mln takeover by Bally's Intralot

Bally's Corporation
Evoke Pharma

Bally's Corporation

BALY

0.00

Evoke Pharma

EVOK

0.00

** Shares in Evoke EVOK.L up 12.5% at 45p, top gainer on the FTSE smallcaps .FTSC index

** Shares touch highest level since October 2025

** Bally's Intralot BYLOTr.AT to buy the British bookmaker for £243.1 million ($326 million) or 52 pence per share

** Intralot’s offer is at a 33.8% premium to EVOK’s closing price before co confirmed discussions with the Greek lottery and gaming firm

** Up to last close, EVOK up ~80% this year


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.